HK30981A - Pharmaceutical compositions containing pirbuterol and hydroxyzine - Google Patents
Pharmaceutical compositions containing pirbuterol and hydroxyzineInfo
- Publication number
- HK30981A HK30981A HK309/81A HK30981A HK30981A HK 30981 A HK30981 A HK 30981A HK 309/81 A HK309/81 A HK 309/81A HK 30981 A HK30981 A HK 30981A HK 30981 A HK30981 A HK 30981A
- Authority
- HK
- Hong Kong
- Prior art keywords
- rti
- hydroxyzine
- pirbuterol
- sep
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71790576A | 1976-08-26 | 1976-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK30981A true HK30981A (en) | 1981-07-10 |
Family
ID=24883964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK309/81A HK30981A (en) | 1976-08-26 | 1981-07-02 | Pharmaceutical compositions containing pirbuterol and hydroxyzine |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5329935A (cs) |
| AU (1) | AU503877B2 (cs) |
| BE (1) | BE858094A (cs) |
| CA (1) | CA1092028A (cs) |
| DE (1) | DE2737735C3 (cs) |
| DK (1) | DK354377A (cs) |
| FR (1) | FR2362629A1 (cs) |
| GB (1) | GB1541991A (cs) |
| GR (1) | GR68687B (cs) |
| HK (1) | HK30981A (cs) |
| IE (1) | IE45768B1 (cs) |
| IL (1) | IL52588A (cs) |
| LU (1) | LU78022A1 (cs) |
| MY (1) | MY8100263A (cs) |
| NL (1) | NL170367C (cs) |
| NZ (1) | NZ184746A (cs) |
| PT (1) | PT66866B (cs) |
| SE (1) | SE7708307L (cs) |
| ZA (1) | ZA774474B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63156327U (cs) * | 1987-04-02 | 1988-10-13 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2899436A (en) * | 1959-08-11 | chjch | ||
| US3700681A (en) * | 1971-02-16 | 1972-10-24 | Pfizer | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines |
| US3786160A (en) * | 1971-02-16 | 1974-01-15 | Pfizer | Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators |
-
1977
- 1977-07-18 SE SE7708307A patent/SE7708307L/xx unknown
- 1977-07-23 GR GR54026A patent/GR68687B/el unknown
- 1977-07-25 IL IL52588A patent/IL52588A/xx unknown
- 1977-07-25 ZA ZA00774474A patent/ZA774474B/xx unknown
- 1977-07-26 NZ NZ184746A patent/NZ184746A/xx unknown
- 1977-07-28 AU AU27412/77A patent/AU503877B2/en not_active Expired
- 1977-07-29 PT PT66866A patent/PT66866B/pt unknown
- 1977-08-08 NL NLAANVRAGE7708732,A patent/NL170367C/xx not_active IP Right Cessation
- 1977-08-09 DK DK354377A patent/DK354377A/da not_active Application Discontinuation
- 1977-08-09 CA CA284,372A patent/CA1092028A/en not_active Expired
- 1977-08-22 DE DE2737735A patent/DE2737735C3/de not_active Expired
- 1977-08-23 GB GB7735281A patent/GB1541991A/en not_active Expired
- 1977-08-25 BE BE180416A patent/BE858094A/xx not_active IP Right Cessation
- 1977-08-25 JP JP10218177A patent/JPS5329935A/ja active Pending
- 1977-08-25 IE IE1770/77A patent/IE45768B1/en not_active IP Right Cessation
- 1977-08-25 LU LU78022A patent/LU78022A1/xx unknown
- 1977-08-25 FR FR7725959A patent/FR2362629A1/fr active Granted
-
1981
- 1981-07-02 HK HK309/81A patent/HK30981A/en not_active IP Right Cessation
- 1981-12-30 MY MY263/81A patent/MY8100263A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2737735B2 (de) | 1979-03-08 |
| PT66866B (en) | 1978-12-29 |
| FR2362629B1 (cs) | 1980-07-11 |
| NZ184746A (en) | 1980-02-21 |
| NL7708732A (nl) | 1978-02-28 |
| DK354377A (da) | 1978-02-27 |
| IL52588A (en) | 1980-07-31 |
| ZA774474B (en) | 1978-06-28 |
| DE2737735A1 (de) | 1978-03-02 |
| IE45768B1 (en) | 1982-11-17 |
| DE2737735C3 (de) | 1979-10-25 |
| AU2741277A (en) | 1979-02-01 |
| NL170367C (nl) | 1982-11-01 |
| LU78022A1 (fr) | 1979-05-23 |
| CA1092028A (en) | 1980-12-23 |
| MY8100263A (en) | 1981-12-31 |
| IE45768L (en) | 1978-02-28 |
| BE858094A (fr) | 1978-02-27 |
| AU503877B2 (en) | 1979-09-27 |
| JPS5329935A (en) | 1978-03-20 |
| GB1541991A (en) | 1979-03-14 |
| FR2362629A1 (fr) | 1978-03-24 |
| SE7708307L (sv) | 1978-02-27 |
| PT66866A (en) | 1977-08-01 |
| IL52588A0 (en) | 1977-10-31 |
| GR68687B (cs) | 1982-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1045695B1 (en) | Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease | |
| US6656915B1 (en) | Inhibiting T-cell proliferation | |
| US4438138A (en) | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone | |
| GB2170707A (en) | An immuno-regulator | |
| US4766117A (en) | Antiinflammatory compositions and methods | |
| EP0399051B1 (en) | Polyvalent antiinflammatory agent | |
| EP0190851B1 (en) | Improved antiinflammatory composition | |
| EP0222575B1 (en) | Prazosin-pirbuterol combination for bronchodilation | |
| EP0448029B1 (en) | Novel pharmaceutical uses of forskolin derivatives | |
| EP0038567B1 (en) | Deazapurine nucleoside, formulations thereof, and use thereof in therapy | |
| WO2025041166A1 (en) | Stable oral liquid formulations containing metoprolol or salts thereof | |
| HK30981A (en) | Pharmaceutical compositions containing pirbuterol and hydroxyzine | |
| EP0149519B1 (en) | Use of quinolones for the manufacture of a composition for the treatment of heart failure. | |
| US4175128A (en) | Method for treating congestive heart failure | |
| IE862599L (en) | Antiinflammatory compositions | |
| JPH06172187A (ja) | 筋ジストロフィー症治療薬 | |
| WO2005007191A1 (ja) | 医薬組成物 | |
| US4391809A (en) | Methods for treating psoriasis | |
| US4348407A (en) | Orally active tolciclate and tolnaftate | |
| WO1991006863A1 (en) | Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents | |
| US4061756A (en) | Methods for treating cardiovascular disorders | |
| US3821381A (en) | Method of treatment | |
| US4672061A (en) | Antiinflammatory compositions and methods | |
| USRE32145E (en) | Orally active tolciclate .[.(and tolnaftate).]. | |
| JPH09500646A (ja) | アザスピランによるｈｉｖの治療法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |